Teresa Tarragó: “Crowdfunding is a Source of Financing for Early Stage Biotechs”
Labcritics was at Iproteos’ facilities talking to Teresa Tarragó, CEO and co-founder of this innovative company. Iproteos combines computational chemistry with modern synthesis methods to generate peptidomimetics with pharmacological activity against diseases such as schizophrenia. We had the opportunity to know about the possibilities of crowdfunding for biotech projects and the technology used in their laboratory.
Visit iproteos.com
Labcritics Alerts / Sign-up to get alerts on discounts, new products, apps, protocols and breakthroughs in tools that help researchers succeed.
